Porton Pharma Solutions is a China-based external manufacturing partner and strategic supplier of custom drug intermediates and Active Pharmaceutical Ingredients (APIs). Porton’s process chemists, engineers and analytical scientists collectively bring decades of proven experience in route elucidation, development, characterization and optimization for the synthetic chemistry processes. Porton services include the development and scale-up of small molecule manufacturing processes to enable mid/late-stage clinical development, launch planning and late life-cycle management. Equipped with three Process Technology Centers and three Manufacturing Sites across China (including one US FDA-approved facilities), Porton sites are operated to global quality and environmental standards under a centralized management system.